These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16482700)

  • 1. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin.
    Chantelau E
    Diabetes Care; 2006 Feb; 29(2):477; author reply 477-8. PubMed ID: 16482700
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.
    Heise T; Bott S; Tusek C; Stephan JA; Kawabata T; Finco-Kent D; Liu C; Krasner A
    Diabetes Care; 2005 Sep; 28(9):2161-9. PubMed ID: 16123484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human insulin and insulin pumps.
    Shuman CR
    Clin Ther; 1984; 6(4):380-7. PubMed ID: 6380721
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion.
    Scheen AJ; Henrivaux P; Jandrain B; Lefebvre PJ
    Diabetes Care; 1986; 9(6):673-4. PubMed ID: 3803158
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled insulin in type 1 diabetes.
    Cavallo MG; Coppolino G; Romeo S; Pozzilli P
    Lancet; 2001 Jun; 357(9272):1980. PubMed ID: 11430391
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of therapy-induced insulin antibodies on glycemic control in type 1 diabetes mellitus.
    Keilacker H; Rjasanowski I; Ziegler M
    Z Med Lab Diagn; 1989; 30(1):65-6. PubMed ID: 2655328
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 10. Mixing short and intermediate acting insulins in the syringe: effect on postprandial blood glucose concentrations in type I diabetics.
    Heine RJ; Bilo HJ; Sikkenk AC; van der Veen EA
    Br Med J (Clin Res Ed); 1985 Jan; 290(6463):204-5. PubMed ID: 3917752
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin, insulin antibodies and insulin autoantibodies.
    Winter WE; Jacobsen LM; Pittman D
    MLO Med Lab Obs; 2017 Feb; 49(2):16-18. PubMed ID: 30005474
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 13. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
    Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W
    Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin therapy in insulin-dependent (type I) diabetes mellitus.
    Nolte MS
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):281-312. PubMed ID: 1612067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological considerations as a guide to the rational use of insulin.
    Ewart R
    J Ky Med Assoc; 1986 Mar; 84(3):104-7. PubMed ID: 3514777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perspectives of inhaled insulin treatment].
    Chodorowski Z; Sein Anand J
    Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of insulin via subcutaneous catheter.
    Wredling RA; Adamson UK; Lins PE
    Diabetes Care; 1994 Jun; 17(6):626-7. PubMed ID: 8082542
    [No Abstract]   [Full Text] [Related]  

  • 18. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
    Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
    Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled insulin.
    Arnolds S; Heise T
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):555-71. PubMed ID: 18054735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.